iQureListed
iqurepharma.combiotech_life_sciences
iQure Pharma is a clinical-stage biotech company developing first-in-class astrocyte-targeted therapeutics designed to restore glutamate balance in CNS disorders.
Portfolio
A closer look at the companies associated with this firm. Verified team members can update the portfolio after signing in.
This is the portfolio currently shown on the public firm page.
iQure Pharma is a clinical-stage biotech company developing first-in-class astrocyte-targeted therapeutics designed to restore glutamate balance in CNS disorders.
Epion Therapeutics is developing a minimally-invasive treatment for ectatic corneal disease that can bring early intervention to millions of patients globally. Their EpiSmart appr…
Oxford Cancer Analytics is helping physicians make better decisions through evidence based diagnostics based on combining modern machine learning AI with reproducible, high throug…
HyliDx is focused on developing innovative diagnostic solutions to address critical healthcare challenges.
Immunobio is involved in the fields of biomarker research and immuno-oncology, focusing on personalized medicine and cancer treatment innovations.
4D Lifetec is a pioneering company specializing in non-invasive, immuno-oncological blood testing for early cancer detection. Their proprietary DDS biomarker has shown high sensit…
52North is a medical technology company focused on transforming emergency care through innovative diagnostic and digital solutions. Their products include portable blood tests and…